StonvexLoading…
StonvexStonvexStonvexCore line items from OC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $10.10B | $9.85B | $8.37B | $9.76B |
Operating Income | $360.00M | $1.48B | $1.64B | $1.71B |
Net Income | $-522.00M | $647.00M | $1.20B | $1.24B |
EPS (Diluted) | $-6.22 | $7.37 | $13.14 | $12.70 |
Total Assets | $12.98B | $14.07B | $11.24B | $10.75B |
Total Liabilities | $9.09B | $8.96B | $6.03B | $6.13B |
Cash & Equivalents | $345.00M | $321.00M | $1.61B | $1.10B |
Free Cash Flow OCF − CapEx | $962.00M | $1.25B | $1.19B | $1.31B |
Shares Outstanding | 80.20M | 85.40M | 87.20M | 91.90M |